Active, not recruitingPhase 2NCT06643481
A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Novartis Pharmaceuticals
- Principal Investigator
- Novartis PharmaceuticalsNovartis Pharmaceuticals
- Intervention
- VHB937(biological)
- Enrollment
- 251 enrolled
- Eligibility
- 18-100 years · All sexes
- Timeline
- 2024 – 2028
Study locations (30)
- University of California San Diego, La Jolla, California, United States
- Loma Linda University Health, Loma Linda, California, United States
- Keck Medical Center USC, Los Angeles, California, United States
- UC San Francisco Medical Center, San Francisco, California, United States
- University of Miami, Miami, Florida, United States
- Orlando Health Clinical Trials, Orlando, Florida, United States
- Emory University School of Medicine, Atlanta, Georgia, United States
- University Of Kansas Medical Center, Kansas City, Kansas, United States
- Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Neurology Associates P C, Lincoln, Nebraska, United States
- University of Nebraska Medical Center, Omaha, Nebraska, United States
- Lange Neurology PC, New York, New York, United States
- University of Rochester Medical Center, Rochester, New York, United States
- Atrium Health, Charlotte, North Carolina, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06643481 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)
- RECRUITINGPHASE3NCT07322003Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALSPrilenia